Dr. Natalie Borodoker, MD

Dr. Borodoker practices at Eye Surgery & Aesthetics in Staten Island, New York.

Dr. Borodoker's NPI, 1750396313, was assigned on July 30, 2006. Dr. Borodoker graduated from New York University School of Medicine in 2002. Dr. Borodoker holds New York license 229403-1.

Dr. Borodoker's primary practice is Eye Surgery & Aesthetics, at 35 Coverly Ave, Staten Island, NY 10301-4549. The practice phone is (718) 448-0588.

Dr. Borodoker's primary practice is Eye Surgery & Aesthetics in Staten Island, New York.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Borodoker practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Borodoker's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Borodoker is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Borodoker's licenses on file in 2 states: New York and Florida.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Borodoker treats.

CMS data shows 4,215 Medicare services from Dr. Borodoker across 22 procedure codes in 2024, for 747 Medicare patients. Medicare paid $319,518 for them.

CMS counts 747 Medicare patients who saw Dr. Borodoker in 2024. The largest group is 75 to 84, with 280 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 79% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Borodoker's median patient age at 68, with 63% women.

In 2024, Dr. Borodoker wrote 3,729 Medicare Part D claims for 646 patients. 54% of them were for generic drugs. CMS names the drug for 3,647 of them, across 32 drugs with 11 or more claims each, at $403,080 in total drug cost. In 2023, CMS named 3,690 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Borodoker for performance year 2024, reported individually. Dr. Borodoker accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 132 procedures of cataract surgery by Dr. Borodoker, more than 78% of the clinicians it reports for that procedure.

Dmand AI links 7 papers to Dr. Borodoker. The most frequent topics are Fluorescein Angiography, Retinal Diseases and Coloring Agents. Dr. Borodoker has published most often in Arch Ophthalmol. Dr. Borodoker's most frequent co-author is Emmett T. Cunningham, MD, MPH, PhD.

CMS Open Payments shows 135 general payments to Dr. Borodoker from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Eyevance Pharmaceuticals LLC paid the most, $288.

Dmand AI lists 1 award for Dr. Borodoker.

Dr. Borodoker graduated from New York University School of Medicine in 2002. Dr. Borodoker is a member of AAO.

Dr. Borodoker is in network with 17 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.